Electrophysiology

Conduction system pacing (CSP) portfolio

Driven by the lumenless advantage

Offering a comprehensive portfolio engineered for trusted stability and proven performance, driven by our exclusive lumenless lead design

To view the indications, safety, and warnings, scroll down or click on one of the links below to jump you down the page to that product.

C315 delivery catheter
C320LBB delivery system
Medtronic™ rotatable connector 5944RL
OmniaSecure™ defibrillation lead
SelectSecure™ pacing lead
SelectSite™ deflectable catheter system

C315 delivery catheter

C315 Delivery Catheter ISW

Indications (or intended use)

The C315 is indicated for the introduction of various types of pacing or defibrillator leads and catheters.

Contraindications

Use of the C315 percutaneous catheter is contraindicated in patients with obstructed or inadequate vasculature.

Warnings and Precautions

This device is intended only to be used once for a single patient. Do not reuse, reprocess, or resterilize this device for purpose of reuse. Reuse, reprocessing, or resterilization may compromise the structural integrity of the device or create a risk of contamination of the device that could result in patient injury, illness, or death.
Keep external defibrillation equipment nearby for immediate use during insertion, placement, acute lead system testing, or whenever arrhythmias are possible or intentionally induced. Backup pacing should be readily available during implant. Use of a delivery system and/or leads may cause heart block. For further information about this and other potential adverse events or complications, refer to the technical manual packaged with the appropriate product.
Use care when passing a catheter through vessels and tissue. Avoid damage, such as perforations and dissections, to vessels and cardiac tissue, during catheter passage and positioning. Do not push, pull, or rotate the catheter against resistance. If resistance is met, discontinue movement, determine the reason for resistance, and take appropriate action before continuing. Damage to the catheter may prevent it from performing with accurate torque response and control, and may cause vessel damage.
Use the catheter only with compatible transvenous devices. No test data is available to demonstrate compatibility of any non-Medtronic device with the catheter. Consequences of using the catheter with incompatible devices may include the inability to deliver the transvenous device or damage to the transvenous device or catheter during delivery. Slitting evaluations on this product were conducted using Medtronic Universal II or Medtronic Adjustable Slitters. These are the only slitters recommended for use with the C315 catheter.
Handle the catheter with care at all times. Do not kink, stretch, or severely bend the catheter. Do not use surgical instruments to grasp the catheter. Do not use excessive force when inserting a catheter into a vessel. Ensure the catheter is thoroughly flushed and free of air prior to use. Avoid contact with liquids other than blood, saline, or contrast solution. Use in conjunction with fluoroscopic guidance and proper anticoagulation agents.
Use the side port on the hub to flush the catheter. The catheter must be thoroughly flushed and free of air prior to use. When using the side port, consider sealing the proximal opening of the hemostatic valve with a thumb or forefinger.

Potential Adverse Events or Potential Complications

Air embolism, allergic reaction to contrast media, arteriovenous fistula formation, bleeding at the insertion site, brachial plexus injury, cardiac tamponade, dislodgement, dissection, endocarditis, heart block, hematoma formation, hemothorax, infection, irregular heart beat, mediastinal widening, perforation, pneumothorax, subclavian artery puncture, thrombophlebitis, thrombosis, valve damage, vascular occlusion, vessel damage.

See the device instructions for use for detailed information regarding the procedural instructions, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 1-800-328-2518 and/or consult the Medtronic website at www.medtronic.com.

Caution: Federal law (United States) restricts these devices to sale by or on the order of a physician.

MAJ_82958

C320LBB delivery system

C320LBB Delivery System ISW

Indications (or Intended Use)

This non-therapeutic delivery system is intended to aid in the introduction and placement of cardiac leads into the right chambers of the heart. The leads are implanted in patients who are indicated for a cardiac implantable electronic device (CIED) for treatment of heart rhythm disorders. Refer to the respective CIED instructions for use for details about the types of heart rhythm abnormalities or patient conditions treated by each type of CIED.

Contraindications

The delivery system is contraindicated for use in the following situations:

In patients with obstructed or inadequate vasculature for venous access.
In patients with a mechanical tricuspid heart valve for placement of a lead in the right ventricle.

Warnings and Precautions

Transvenous Device compatibility – Use the delivery system only with compatible transvenous devices and compatible leads. No test data is available to demonstrate compatibility of the catheter with any device not manufactured by Medtronic. Consequences of using the catheter with incompatible devices may include the inability to deliver the transvenous device or damage to the transvenous device or catheter during delivery.
Slitting evaluations on this product were conducted using Medtronic Universal II or Medtronic Adjustable Slitters. These are the only slitters recommended for use with the C320LBB delivery catheter.

Single use – The delivery system is for single use only and is not intended to be resterilized or reused. Reuse, reprocessing, or resterilization may compromise the structural integrity of the product or create a risk of contamination of the product, which could result in patient injury, illness, or death.

Sterile package inspection – Before opening the sterile package, visually check for any signs of damage that might invalidate the sterility of the contents. If the package is damaged, contact a Medtronic representative.

Storage conditions – There are no special handling, including no special storage conditions, required for this device. Standard storage conditions are sufficient to safeguard the device. Store the device in the original packaging at room temperature in a dry place.

“Use-by” date – Check to verify that the product is within the expiration date. Do not use the product after the “Use-by” date on the package label.

Sterilization – Medtronic has sterilized the package contents with ethylene oxide before shipment. Do not clean or resterilize the delivery system. Dispose of the product after use according to local environmental requirements.

Handling the catheter – Handle the catheter and dilator with care at all times.

Do not kink, stretch, or severely bend the catheter.
Do not use surgical instruments to grasp the catheter shaft.
Do not use excessive force when inserting a catheter into a vessel.
Before use, ensure that the catheters are thoroughly flushed with saline or heparinized saline and free of air to avoid air embolism to the patient.
Avoid contact with liquids other than blood, saline, heparin, or contrast solution.

Vessel and tissue damage – Use care when passing a catheter through vessels and tissue. To avoid damaging tissue or the tip of the catheter assembly, keep the catheter dilator fully inserted into the catheter during passage to the right atrium. To minimize risk of perforation and dissection, do not push, pull, or rotate the catheter against resistance. If resistance is met, discontinue movement, determine the reason for resistance, and take appropriate action before continuing. Damage to the catheter may prevent it from performing with accurate torque response and control.

Flushing the delivery system – The catheters and dilators must be thoroughly flushed and free of air before use. Do not use a power injection syringe to inject contrast solution.

Necessary hospital equipment – Keep external defibrillation equipment nearby for immediate use during insertion, placement, acute lead system testing, or whenever arrhythmias are possible or intentionally induced. Backup pacing should be readily available during implant. Use of a delivery system, leads, or both may cause heart block. For further information about this and other potential adverse events or complications, refer to the technical manual packaged with the appropriate product.

Perforation – Due to the relative stiffness of the catheter, damage to the walls of the vessels may include perforations or dissections. When in the right chamber of the heart, the guide-catheter dilator must be retracted within the outer guide catheter tip to minimize the risk of perforation.

Review the lead documentation – Because the delivery systems are used in the lead implantation procedure, it is recommended that the lead documentation be reviewed for all appropriate warnings, complications, and precautions.

Small-bore connectors – This medical device uses an alternative small-bore connector design different from those specified in the ISO 80369 series. Because of this, there is a possibility that a misconnection could occur between this medical device and a medical device using a different or alternative small-bore connector. Such a misconnection could result in a hazardous situation that could potentially cause harm to the patient. Special measures need to be taken by the user to mitigate these reasonably foreseeable risks.

Potential Adverse Events or Potential Complications

Potential complications include, but are not limited to air embolism, allergic reaction, cardiac inflammation, cardiac perforation, cardiac valve damage, embolism, infection, lead dislodgement, pericardial effusion, physical injury, subclavian artery puncture, thrombosis, hemorrhage, hemothorax, tissue trauma, vascular tear.

See the device manuals for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 800-328-2518 and/or consult Medtronic’s website at www.medtronic.com.

Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.

MIN_92423

Medtronic™ rotatable connector 5944RL

Medtronic™ Rotatable Connector 5944RL ISW

Indications

The rotatable connector is intended for use as part of a temporary cardiac pacing system. It connects a Medtronic cardiovascular stimulating instrument to a Medtronic cardiac pacing lead. It is intended for use by trained clinicians in a clinical environment.

For more information about the temporary cardiac pacing system, including indications for use, refer to the technical manuals for the cardiovascular stimulating instruments.

The device is used as part of a temporary cardiac pacing system based on the principle of transmitting electrical signals between the cardiovascular stimulating instrument and the cardiac pacing leads. The device allows real-time continuous and accurate pacing and sensing electrical connection during lead implantation. After the implantation procedure is finished, the device is disconnected and discarded.

The rotatable connector is intended to be used with:

Medtronic cardiovascular stimulating instruments
Medtronic implanted IS-1 leads
Medtronic implanted IS-4/DF-4 leads

Contraindications

There are no known contraindications for the Model 5944RL rotatable connector.

General warnings and precautions

Cable handling — When handling the cables, do not allow the exposed metal to contact electrically conductive surfaces or wet surfaces other than the cardiac pacing leads. Do not touch the exposed metal conductive surfaces.

Connection order — Connect the rotatable connector cable system to the cardiovascular stimulating instrument before connecting it to the pacing leads and/or unipolar reference. When disconnecting the cable, disconnect from the pacing leads and/or unipolar reference before disconnecting from the cardiovascular stimulating instrument.

Do not modify — Do not modify this equipment. Modifications may reduce system effectiveness and impact patient health and safety.

Humidity — Do not expose the cable to humidity greater than 95%.

If the package information is damaged – If any information on the outer package is defaced or damaged so that you cannot read it, do not use, and notify Medtronic.

Inspecting the sterile package – Inspect the sterile package and cables with care before opening it.

Contact a Medtronic representative if the seal, package, or cable is damaged.
Do not use the product after its expiration date.

Product compatibility — This accessory has not been tested for use with non-Medtronic products.

Review the system documentation — Because the cable system is part of a cardiac pacing system, review all applicable documentation for warnings, complications, precautions, and instructions.

Single-use — This device is intended for single use only. Do not reuse, reprocess, or resterilize this device for the purpose of reuse. Reuse, reprocessing, or resterilization may compromise the structural integrity of the device which could impact performance or create a risk of contamination of the device that could result in patient injury, illness, or death.

Storage temperature — Do not expose the cables to storage temperatures above 30°C (86°F) or below 15°C (59°F).

Transit temperature — Do not expose the cable package to transit temperatures above 70°C (158°F) or below -40°C (-40°F).

Technical manual information — If you find information in this manual that is incorrect or illegible, contact your Medtronic representative.

Product Disposal — The device described in this document must be disposed of in compliance with local, state, or federal guidelines regulating the disposal of such products.

Potential adverse events

These are the potential adverse events that can occur or can require intervention when using this device:

Allergic reaction
Cardiac arrest
Discomfort
Dizziness
Fever
Infection
Lethargy
Patient cut, or skin pinched or irritated
Property or environmental damage
Skin disorders
Syncope and/or medical intervention
Toxic reaction

Note: If a serious incident related to the device occurs, immediately report, immediately report the incident to Medtronic and the applicable competent authority or regulatory body.

MAJ_89507

OmniaSecure™ defibrillation lead

OmniaSecure™ Defibrillation Lead ISW

Indications

The Model 3930M family of leads are intended for use in the right ventricle (RV) or for placement in the left bundle branch area as an alternative to right ventricular stimulation sensing, pacing, cardioversion, and defibrillation when a cardiac implantable electronic device is indicated to treat patients who have experienced, or are at significant risk of developing, life-threatening tachyarrhythmias.

This includes adolescent pediatric patients who are at least 30 kg and are also at least 12 years of age, and whose cardiac anatomy is conducive to RV coil placement.

Contraindications

The Model 3930M family of leads are contraindicated for use in the following situations:

Non-right ventricular use – The lead is contraindicated for non-right ventricular implant sites including the His bundle and the atrial side of the tricuspid valve annulus.
Tricuspid valvular disease or mechanical tricuspid valve – The lead is contraindicated in patients with tricuspid valvular disease or a mechanical tricuspid valve.
Steroid use – The lead is contraindicated in patients for whom a single dose of 1.0 mg of dexamethasone acetate may be contraindicated.
Transient ventricular tachyarrhythmias –The lead is contraindicated if tachyarrhythmias with transient or reversible causes exist, including the following known issues: acute myocardial infarction, drug intoxication, drowning, electric shock, electrolyte imbalance, hypoxia, sepsis.
Intravenous Catheterization – The leads are contraindicated in patients with obstructed or inadequate vasculature for intravenous catheterization.

Warnings and Precautions

Handling the lead – Handle the lead with care at all times. Do not implant the lead if it is damaged. Do not attempt to straighten or realign the helix if the helix is deformed. Return the lead to your Medtronic representative in either event.

Repositioning or removal of an acute lead – Successfully repositioning the lead depends on recreating the angle and advancement of the catheter present at the time of initial helix deployment at implant (relative to the lead helix and endocardium). Proper orientation helps transfer torque to the helix. This increases the likelihood of successfully disengaging the helix from the endocardium. Improper removal of the lead by pulling may result in avulsion of the endocardium.

Extraction or removal of a chronic lead – Proceed with caution if a chronically implanted lead must be removed or extracted. Lead extraction procedures should be consistent with the most recent editions of HRS or EHRA expert consensus statements regarding cardiovascular implantable electrode device lead management and extraction. Market released extraction tools or clinically recognized techniques may be used to help facilitate extraction. When the risk of lead extraction outweighs the benefit, it may be preferable to abandon unused leads and leave in place. Return all removed leads, unused leads, or lead sections to Medtronic for analysis.

Connector compatibility – Although Medtronic lead connectors conform to International Connector Standards, this lead has not been tested for use with non-Medtronic devices. The known potential adverse consequences of using such a combination may include undersensing of cardiac activity, failure to deliver necessary therapy, or an intermittent electrical connection.

Electrophysiologic testing – Electrophysiologic evaluation and testing should be performed at the discretion of the physician taking into consideration the current clinical guidelines.

Potential Adverse Events

The following are known potential complications associated with the use of this product: Allergic reaction; AV fistula; Bradyarrhythmia; Cardiac arrest; Cardiac inflammation; Cardiac perforation; Cardiac tamponade; Cardiac valve damage; Discomfort; Dislodgement; Dizziness; Dyspnea; Embolism; Erosion; Extracardiac stimulation; Excessive fibrotic tissue growth; Fever; Heart block; Heart failure decompensation (hospitalization); Hematoma; Hemorrhage; Hemothorax; Hiccups; Hospitalization; Inappropriate shock; Infection; Insulation failure; Lead fracture; Lethargy; Loss of capture; Loss of pacing; Mental anguish; Nerve damage; Oversensing; Palpitations; Pericardial effusion; Pneumothorax; Return of cardiac symptoms; Septal wall perforation; Seroma; Skeletal muscle sensation or twitching; Skin disorders; Stroke; SVC tear; Syncope; Tachyarrhythmia; Threshold elevation; Thrombosis; Tissue trauma; Toxic reaction; Tricuspid valve regurgitation; Undersensing; Vascular tear; Venous occlusion; Vessel perforation.

See the MRI SureScan Technical Manual before performing an MRI scan. Consult Lead Technical Manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 1-800-328-2518 and/or consult Medtronic’s website at www.medtronic.com or www.mrisurescan.com.

Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.

US-CV-2600618 v1.0

SelectSecure™ pacing lead

SelectSecure™ Pacing Lead ISW

Indications

Medtronic SelectSecure™ family of leads has application where implantable atrial or ventricular, single-chamber or dual-chamber pacing systems are indicated. The Model 3830 lead is intended for pacing and sensing in the atrium or ventricle.

Medtronic SelectSecure™ MRI family of leads is intended for pacing and sensing in the atrium or right ventricle. It is also intended for pacing and sensing at the bundle of His or in the left bundle branch area as an alternative to right ventricular pacing in a single or dual chamber pacing system.

SelectSecure™ MRI SureScan™ leads (specified lengths of Model 3830 including 59, 69 and 74 cm) are MR Conditional and indicated for pacing and sensing at the bundle of His or in the left bundle branch area as an alternative to right ventricular pacing in a single or dual chamber pacing system. The Model 3830 lead is part of the Medtronic SureScan™ system. The SureScan™ system includes a Medtronic SureScan™ device connected to Medtronic SureScan™ leads.

Contraindications

SelectSecure™ lead family is contraindicated for the following:

ventricular use in patients with tricuspid valvular disease or a tricuspid mechanical heart valve.
patients for whom a single dose of beclomethasone dipropionate may be contraindicated; see manual for specific dosage.

The SelectSecure™ Model 3830 lead is also contraindicated for patients with obstructed or inadequate vasculature for intravenous catheterization.

Warnings and precautions

People with metal implants such as pacemakers, implantable cardioverter defibrillators (ICDs) and accompanying leads should not receive certain forms of diathermy treatment. Diathermy treatments may result in serious injury or damage to an implanted device and lead system. Some lead models allow the use of therapeutic ultrasound; consult individual lead model technical manuals for more detail.

For Model 3830, total patient exposure to beclomethasone 17,21-dipropionate should be considered when implanting multiple leads. No drug interactions with inhaled beclomethasone 17,21-dipropionate have been described. Drug interactions of beclomethasone 17,21-dipropionate with the Model 3830 lead have not been studied.

Do not use magnetic resonance imaging (MRI) on patients who have non-MR Conditional versions/lengths of these leads implanted as part of a complete SureScan™ system. MRI can induce currents on implanted leads, potentially causing tissue damage and the induction of tachyarrhythmias.

MRI SureScan™ leads only: A complete SureScan™ pacing or defibrillation system is required for use in the MR environment. Before performing an MRI scan, refer to the MRI technical manual for MRI-specific warnings and precautions. Patients and their implanted systems must be screened to meet the following requirements for MRI: no implanted lead extenders, lead adaptors, or abandoned leads; no broken leads or leads with intermittent electrical contact as confirmed by lead impedance history; a SureScan™ defibrillation system implanted in the left or right pectoral region; pacing capture thresholds of ≤ 2.0 V at a pulse width of 0.4 ms; no diaphragmatic stimulation at a pacing output of 5.0 V and at a pulse width of 1.0 ms in patients whose device will be programmed to an asynchronous pacing mode when MRI SureScan™ is programmed to ”on.. Patients may be scanned using a horizontal field, cylindrical bore, clinical 1.5T or 3T MRI system for hydrogen proton imaging.

Potential complications

Potential patient-related complications related to the use of transvenous leads include, but are not limited to, valve damage, fibrillation and other arrhythmias, thrombolytic and air embolism, cardiac perforation, heart wall rupture, cardiac tamponade, muscle or nerve stimulation, pericarditis, pericardial rub, infection, myocardial irritability, thrombosis and pneumothorax. Other potential lead-related complications may include exit block, lead dislodgement, lead fracture, insulation failure, and threshold elevation.

Potential MRI complications include, but are not limited to, lead electrode heating and tissue damage resulting in loss of sensing or capture or both, or induced currents on leads resulting in continuous capture, VT/VF, and/or hemodynamic collapse.

See the appropriate Device MRI SureScan™ technical manual before performing an MRI scan and lead technical manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 1-800-328-2518 and/or consult the Medtronic website.

Caution: Federal law (United States) restricts this device to sale by or on the order of a physician.

Rev 10/22

MAJ_90561

SelectSite™ deflectable catheter system

SelectSite™ Deflectable Catheter System ISW

Indications (or Intended Use)

The device is indicated to provide a pathway through which diagnostic and therapeutic transvenous devices are introduced within the chambers and coronary vasculature of the heart and for introducing balloon catheters into the coronary sinus or leads into vessels of the left heart via the coronary sinus.

Contraindications

Use of the device is contraindicated for patients with obstructed or inadequate vasculature and for right ventricular use in patients with tricuspid valvular disease or a mechanical tricuspid heart valve.

Warnings and Precautions

The device is for single use only and is not intended to be resterilized.
Use the deflectable catheter only with compatible transvenous devices. No test data is available to demonstrate compatibility of the deflectable catheter with any device not manufactured by Medtronic. For the C304 Catheters, no test data is available to demonstrate compatibility of the transvenous devices with an outer diameter larger than 1.5mm (4.6Fr), with the exception of the 1.85mm (5.6Fr) dilator included with the device package. Consequences of using the deflectable catheter with incompatible devices may include the inability to deliver the transvenous device or damage to the transvenous device during delivery.
Thrombogenicity evaluations were conducted using a heparinized model. If your patient cannot be adequately anticoagulated, it is unknown whether thrombus formation may occur with this product.
Handle the deflectable catheter with care at all times. Do not kink, stretch, or severely bend the deflectable catheter. Do not use surgical instruments to grasp the deflectable catheter. Avoid contact with liquids other than isopropyl alcohol, blood, saline, or contrast solution.
Use the valve to impede the back flow of venous blood during the implant procedure. Ensure that the flush port stopcock is closed before attaching the valve to the deflectable catheter hub.
Keep external defibrillation and backup pacing readily available during implant. Use of the device, transvenous devices, or both may cause heart block.

Potential Adverse Events or Potential Complications

Potential adverse events related to the use of the deflectable catheter may include, but are not limited to, the following events: air embolism, allergic reaction to contrast media, arteriovenous fistula formation, bleeding at the insertion site, brachial plexus injury, cardiac tamponade, dislodgement, dissection, endocarditis, heart block, hematoma formation, hemothorax, infection, irregular heart beat, mediastinal widening, perforation, pneumothorax, subclavian artery puncture, thrombophlebitis, thrombosis, valve damage, vascular occlusion, vessel damage.

Caution: Federal law (United States) restricts these devices to sale by or on the order of a physician.

MAJ_83037

Comprehensive CSP solutions

Delivering end-to-end innovation in CSP tools to enhance the procedure

Trusted lead stability

Our lumenless pacing and defibrillation leads offer a low rate of dislodgement and high rate of implant success.

SelectSecure™ 3830 pacing lead

0.3%

Low rate of dislodgement¹

92.7%

LBBA implant success²

97.5%

Complication-free rate¹

Model 3830 has a

10x lower rate

of LBBAP dislodgement versus stylet-delivered leads, per a physician-initiated meta-analysis study.⁴

OmniaSecure™ defibrillation lead

0.7%

Low rate of dislodgement³

95.4%

LBBA implant success³

97.9%

Complication-free rate³

Proven performance

Demonstrating unmatched evidence of durability in LBBA implants^1,3,5–8

The lumenless lead portfolio delivers proven performance through robust bench testing^† and real-world clinical evidence.

SelectSecure™ 3830 pacing lead

99.98%

Modeled LBBA intracardiac fracture-free rate (400M cycles)⁵

99.9%–100%

De Pooter, et al., through 19.5 months average follow up

Vijayaraman, et al., through 36 months follow up

Real-world fracture-free survival^1,6

OmniaSecure™ defibrillation lead

Predicted to be high⁷

Modeled LBBA intracardiac and shoulder fracture-free rate (400M cycles)

100%

(2.6 months ± 2.5 months’ follow-up)

Real-world fracture-free survival³

† Bench testing may not be representative of actual clinical performance.

The lumenless advantage

Lumenless design

Central cable minimizes lead mechanical stress⁹

Fixed helix

Increased helix reliability at implant⁹

Small French size

Reduces the amount of torque transfer down the lead body, reducing the potential for helix stress and fracture⁹

4.1 Fr SelectSecure™ MRI SureScan™
Model 3830 pacing lead

Sense coil conductor
Cable to tip

4.7 Fr OmniaSecure™ 3930M
defibrillation lead

Sense and defibrillation coil conductor
Pace cable conductor to lead tip

Resources

Related products

† Bench testing may not be representative of actual clinical performance.

Conduction system pacing (CSP) portfolio

C315 delivery catheter

C315 Delivery Catheter ISW

Indications (or intended use)

Contraindications

Warnings and Precautions

Potential Adverse Events or Potential Complications

C320LBB delivery system

C320LBB Delivery System ISW

Indications (or Intended Use)

Contraindications

Warnings and Precautions

Potential Adverse Events or Potential Complications

Medtronic™ rotatable connector 5944RL

Medtronic™ Rotatable Connector 5944RL ISW

Indications

Contraindications

General warnings and precautions

Potential adverse events

OmniaSecure™ defibrillation lead

OmniaSecure™ Defibrillation Lead ISW

Indications

Contraindications

Warnings and Precautions

Potential Adverse Events

SelectSecure™ pacing lead

SelectSecure™ Pacing Lead ISW

Indications

Contraindications

Warnings and precautions

Potential complications

SelectSite™ deflectable catheter system

SelectSite™ Deflectable Catheter System ISW

Indications (or Intended Use)

Contraindications

Warnings and Precautions

Potential Adverse Events or Potential Complications

Comprehensive CSP solutions

The first pacing and defibrillation leads for CSP

Expanding the CSP procedure to the atrium with 3830 BBP tools

Enhancing stability, precision, and versatility in CSP procedures

Trusted lead stability

SelectSecure™ 3830 pacing lead

OmniaSecure™ defibrillation lead

Proven performance

SelectSecure™ 3830 pacing lead

OmniaSecure™ defibrillation lead

The lumenless advantage

Lumenless design

Fixed helix

Small French size

4.1 Fr SelectSecure™ MRI SureScan™ Model 3830 pacing lead

4.7 Fr OmniaSecure™ 3930M defibrillation lead

Resources

Related link

Related products

United States

Customer Care Team

4.1 Fr SelectSecure™ MRI SureScan™
Model 3830 pacing lead

4.7 Fr OmniaSecure™ 3930M
defibrillation lead